GABRA2

Chr 4MultiAD

gamma-aminobutyric acid type A receptor subunit alpha2

Also known as: DEE78, EIEE78

GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]

OMIMResearchGenerating clinical summary…
MultiplemechanismMulti/ADLOEUF 0.232 OMIM phenotypes
Clinical SummaryGABRA2
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
20 unique Pathogenic / Likely Pathogenic· 152 VUS of 370 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.23LOEUF
pLI 0.996
Z-score 4.01
OE 0.05 (0.020.23)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.13Z-score
OE missense 0.42 (0.360.50)
97 obs / 230.7 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.05 (0.020.23)
00.351.4
Missense OE?0.42 (0.360.50)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 1 / 20.7Missense obs/exp: 97 / 230.7Syn Z: 0.49
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongGABRA2-related epileptic encephalopathyOTHERAD

This gene — mechanism propensity

DN
0.6258th %ile
GOF
0.7127th %ile
LOF
0.51top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · LOEUF 0.23
GOFprediction above median · 90% of P/LP are missense
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

LOFAltogether, we identified four heterozygous missense variants in GABRA2 and provided a functional screen that yielded results compatible with a loss of function mechanism.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 31032849

ClinVar Variant Classifications

370 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic14
VUS152
Likely Benign162
Benign18
Conflicting14
6
Pathogenic
14
Likely Pathogenic
152
VUS
162
Likely Benign
18
Benign
14
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
4
0
0
6
Likely Pathogenic
0
14
0
0
14
VUS
21
123
6
2
152
Likely Benign
3
35
53
71
162
Benign
0
2
12
4
18
Conflicting
14
Total261787177366

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap GABRA2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GABRA2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →